STRS Ohio’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-979
Closed -$110K 1926
2016
Q1
$110K Buy
979
+51
+5% +$5.3K ﹤0.01% 1639
2015
Q4
$100K Buy
+928
New +$106K ﹤0.01% 1682
2015
Q3
Sell
-1,734
Closed -$197K 1889
2015
Q2
$197K Sell
1,734
-32,590
-95% -$3.95M ﹤0.01% 1564
2015
Q1
$3.59M Sell
34,324
-169
-0.5% -$18K 0.02% 567
2014
Q4
$4.15M Sell
34,493
-65,700
-66% -$8.63M 0.02% 549
2014
Q3
$14.7M Hold
100,193
0.06% 344
2014
Q2
$16.7M Sell
100,193
-166,800
-62% -$29.7M 0.07% 328
2014
Q1
$53M Sell
266,993
-121,500
-31% -$22.9M 0.24% 127
2013
Q4
$74.2M Sell
388,493
-101,000
-21% -$18.8M 0.33% 75
2013
Q3
$82.8M Sell
489,493
-3,773
-0.8% -$586K 0.37% 67
2013
Q2
$74.8M Buy
+493,266
New +$69.9M 0.32% 73

Other funds holding CLB

STRS Ohio's CLB Position: Q2 2016 in Review

STRS Ohio sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 979 shares — an estimated $110K sold.

STRS Ohio first reported a position in CLB in Q2 2013 and held it in 11 quarters. The position peaked at $82.8M in Q3 2013. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

  • STRS Ohio reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
  • STRS Ohio sold 979 Core Laboratories shares in Q2 2016, an estimated $110K.
  • STRS Ohio first reported a position in Core Laboratories in Q2 2013 and held it in 11 quarters.
  • STRS Ohio's Core Laboratories position peaked at $82.8M in Q3 2013.
  • 383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on STRS Ohio's 13F filing for Q2 2016, filed 26 Jul 2016.